NIH Develops Blood Test to Predict Alzheimer’s Disease Progression
BETHESDA, Md., July 1, 2026 A National Institutes of Health (NIH)-funded study has identified a promising blood-based biomarker that...
pTau217
Advertisement
Roche Gains CE Mark Approval for Elecsys pTau217 Test
BASEL, Switzerland, May 12, 2026 Roche announced that it has received European CE Mark approval for Elecsys® plasma phosphorylated-tau...
Fujirebio Launches Automated pTau217 CSF Assay for Alzheimer’s Research
Tokyo, Japan – January 28, 2026 – Fujirebio, a global leader in in vitro diagnostics and part of H.U....
Alamar Biosciences Launches Blood-Based pTau217 Assay for Alzheimer’s Research
FREMONT, Calif., Oct. 10, 2025 /PRNewswire/ — Alamar Biosciences, a leader in precision proteomics, today announced the launch of...
Advertisement
